The dental bone graft market size was valued at USD 1.45 billion in 2023 and is projected to grow from USD 1.59 Billion in 2024 to USD 3.05 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.49% during the forecast period (2024 - 2030). The main market drivers for Dental Bone Graft market growth are an increase in the density of bone grafts and a rise in the frequency of dental implant surgeries.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
In January 2023, Zimmer Biomet Holdings, Inc., a prominent global leader in medical technology, announced an agreement to buy Embody, Inc., a privately held company that specializes in healthcare products aimed at soft tissue repair. This means that this strategic move demonstrates the intention of Zimmer Biomet to expand its portfolio and expertise in the field of soft tissue healing solutions. In the same vein, using specialized technologies as well as knowledge of soft tissue healing from Embody, Inc., it has further enhanced its offerings and capabilities in this area.
In April 2023, Henry Schein invested in majority ownership of Biotech Dental with plans to establish a seamless customer journey digital workflow, ultimately leading to increased case acceptance and improved clinical outcomes for practitioners.
For example, in April 2022, Aspen Group entered into a multiyear strategic partnership with ACE Surgical Supply, which is one of the bone regenerative product providers for dental bone grafting solutions.
Again For instance, Fredun Pharmaceuticals Limited was given approval by the Central Drugs Standard Control Organisation (CDSCO), India, to produce Xenografts for different dental appliances, including orthopedic surgical appliances. With this goal, the company seeks to capture Indian dentists, especially those supporting implants. The strategy is expected to expedite the growth of xenograft-based dental bone graft substitute production, thereby boosting the entire segment considerably.
In March 2022, Biocomposites signed a distribution agreement with Zimmer Biomet for the new Genex Bone Graft Substitute. Genex Bone Graft Substitute is designed specifically as a biphasic composite having exceptional purity that balances osteoconductive scaffold strength and persistence while remodeling bone architecture.
In March 2022, CGbio signed a five-year deal worth KRW 10 billion ($9 million) with Kerunxi Medical, which is a Chinese-based dental equipment manufacturer for exporting Bongros Dental bone graft materials.
For example, Neoss inked a deal with Purgo Biologics in September 2021 and subsequently became a major partner and distributor of the Purgo Xenograft product range for dental implant solutions in Germany, Sweden, and the United Kingdom markets.
With the advent of cutting-edge surgical methods like bone transplants and bone regeneration, dental implant surgery has recently gained enormous popularity. Additionally, the industry is being stimulated by these surgeries' rising success rates. As of 2019, implant surgeries have been claimed to have a success rate of between 95% and 98%, according to the American Dental Association report. About 5 million implant surgeries are carried out in the United States annually. Before implant placement, bone grafting aids in maintaining the natural jaw and boosts the likelihood of a profitable implant procedure.
In addition, rising demand for medical and dental travel, the prevalence of oral illnesses, and technical developments in dentistry are all critical drivers of market expansion. The market is expanding due to the increasing prevalence of dental problems. For instance, about 530 million children experience caries of their primary teeth, according to the World Health Organization (2020), which estimates that nearly 3.5 billion people are affected by oral disorders.
Before implant insertion, bone grafting is carried out to preserve the natural jaw, which aids in a successful implant procedure. As a result, expanding the usage of these artificial and biocompatible grafts in dental operations finally spurs market expansion. According to a study published in May 2020 and titled "Prevalence of Periodontal Disease and Lack of Its Surveillance," populations from high-income countries and elderly persons are most likely to develop periodontitis. Between low-income (28.7%), lower-middle-income (10%), upper-middle-income (42.5%), and high-income (43.7%) countries, the distribution varied greatly. Therefore, such dental-related medical conditions have recently increased the CAGR for dental bone grafts.
However, the utilization of synthetic and biocompatible dental grafts is another factor driving the growth of the Dental Bone Graft market revenue.
The Dental Bone Graft market data has been bifurcated by type into synthetic bone graft and xenograft. The xenograft Bone Graft segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. A xenograft is a bone obtained from an animal, such as a bovine, into a human being. Bio-Oss is the most often utilized xenograft. Significant players in the market are launching new xenograft products to increase penetration.
April 2019: Marks Biotech Inc. introduced Novobone, a xenograft, to expand its line of bone grafting products. This approval has further broadened the growth opportunity for the Dental Bone Graft industry.
Figure 2: Dental Bone Graft Market, by Type, 2022 & 2030 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Besides, the synthetic bone graft was the fastest-growing segment. Its increased osteoconductivity, hardness, and improved acceptance are responsible for the Dental Bone Graft marketgrowth. There are many kinds of synthetic materials on the market, including ceramic, polymer-based, BMPs, and others. Artificial grafting has a lower risk of disease transmission than xenograft and allograft, which promotes growth even more. This market is also driven by the growing need to create biocompatible grafts to lessen adverse reactions.
Based on Application, the Dental Bone Graft market segmentation has been segmented into socket preservation, ridge augmentation, implant bone regeneration, and others. Socket preservation held the most significant segment share in 2022; socket preservation techniques have increased due to improvements in bone grafting materials, such as the introduction of synthetic bone materials. It is a technique to lessen bone loss following tooth extraction from an alveolar bone tooth socket.
The fastest-growing segment in the Dental Bone Graft market segmentation is ridge augmentation. Due to the easy operation and speedy recovery. This treatment is becoming more and more popular as a means of ensuring long-term survival and successful implant implantation.
The analysis offers Dental Bone Graft market insights for Europe, North America,Asia-Pacific, and the rest of the world, by region. The market for dental bone grafts in North America reached USD 2.702 billion in 2022 and is projected to grow at a significant CAGR throughout the research period. The primary forces driving the market's growth are the strategic moves taken by market players and the increased frequency of dental appointments. For instance, according to Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 people between the ages of 22 and 66 have at least one cavity, and approximately 57% of teenagers between the ages of 12 and 19 have a hole in one or more of their permanent teeth.
Further, the major countries studied in the Dental Bone Graft market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: DENTAL BONE GRAFT MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The second-largest market share is held by Europe dental bone grafts market. Due to the accessibility of dental offices run by professionals, the prevalence of oral health problems, and significant challenges with oral hygiene. Additionally, the UK dental bone graft market grew at the highest rate in the European region, while the Germany dental bone graft market held the most significant market share.
From 2022 to 2030, the Asia-Pacific dental bone graft market is anticipated to expand at the quickest CAGR. A surge in medical tourism and government measures are to blame for the growth. The risk of dental issues is also rising in this area as the population ages. Another element driving the market's growth is dental grafting medical tourism to China and India. In addition, there are more manufacturing facilities in these nations due to the readily available resources, enabling the development of innovative End-Use at a lower cost. The India Dental Bone Graft market had the quickest growth rate in the Asia-Pacific region, while the China Dental Bone Graft market held the highest market share.
Major industry players are spending a lot of effort in R&D to broaden their product offerings, which will spur further market expansion for dental bone grafts. In addition, market participants are launching key developments entering into contracts, acquiring companies, increasing investments, and working with other organizations, among other significant market changes, to expand their footprint. To grow and survive in a market that is becoming more and more competitive, players in the dental bone graft industry must provide affordable goods.
Manufacturing locally to reduce operating costs is one of the leading business tactics suppliers use in the international Dental Bone Graft industry to benefit customers and grow the market sector. The dental bone graft industry has recently given medicine some of the most important advantages. The Dental Bone Graft market major player such as BioHorizons, Geistlich, ACE Surgical, and others are working to expand the market demand by investing in research and development activities.
Dentsply Sirona is an American company that produces dental supplies and equipment and sells its goods in over 120 nations. It operates plants in 21 countries. In January 2021, Dentsply Sirona revealed that it had acquired Datum Dental, Ltd. and its broad array of OSSIX biomaterials. Israel-based Datum Dental is renowned for its cutting-edge dental regeneration solutions that feature the GLYMATRIX unique technology, which is clinically superior.
Also, Neoss provides intelligent products that are logically simple to use. Their solutions enable dental practitioners to offer their patients dependable, economical treatments with predictable long-term outcomes. In September 2021, After signing a contract, Neoss joined Purgo Biologics as a major distributor and partner for the Purgo Xenograft product line for dental implant solutions in the German, Swedish, and British markets.
Stryker Corporation
Johnson & Johnson
Danaher Corporation
LifeNet Health
Osteogenic Biomedical
Strauman
Dentium
Zimmer Dental
RTI Surgical
BioHorizons, IPH, Inc, among others
Dental Bone Graft Industry Developments
March 2022: With Zimmer Biomet, Biocomposites has a contract to distribute the brand-new Genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of extraordinary purity that was created to achieve the ideal balance between osteoconductive scaffold strength and persistence in the body for bone architecture remodeling.
March 2022: For the export of Bongros Dental, a bone graft substance, CGbio signed a five-year contract worth KRW 10 billion with Kerunxi Medical, a Chinese company specializing in dental equipment.
Synthetic Bone Graft
Xenograft
Socket Preservation
Ridge Augmentation
Implant Bone Regeneration
Others
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 1.45 billion |
| Market Size 2024 | USD 1.59 billion |
| Market Size 2032 | USD 3.05 billion |
| Compound Annual Growth Rate (CAGR) | 7.49% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019 - 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Straumann AG, Dentsply Sirona, Zimmer Biomet, Geistlich, Medtronic, BioHorizons IPH, Inc, ACE Surgical Supply Company, Inc., RTI Surgical, Inc, LifeNet Health, Kerr Dental and Dentium |
| Key Market Opportunities | Growing awareness and the rapidly changing technology. |
| Key Market Dynamics | The benefits of dental bone grafting are expanding, as are the number of healthcare organizations. |
Dental Bone Graft Market Highlights:
Frequently Asked Questions (FAQ) :
Dental Bone Graft Market is expected to exhibit a CAGR of 7.49% from 2024-2032.
Dental Bone Graft Market is majorly driven by the large elderly populace.
Dental Bone Graft Market faces challenges of high procedural costs and risks with dental graft procedures.
Europe is expected to dominate the Global Dental Bone Graft Market due to the stark rise in healthcare budget
APAC is expected to display a stupendous growth rate in the Global Dental Bone Graft Market from 2024-2032.
Zimmer Biomet, Dentium, RTI Surgical, Inc, LifeNet Health, Medtronic, BioHorizons IPH, Inc, ACE Surgical Supply Company, Inc., Kerr Dental, Geistlich, Straumann AG, and Dentsply Sirona are major players of the Global Dental Bone Graft Market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
